1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with pirinixic acid in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (pirinixic acid) | Trials (pirinixic acid) | Recent Studies (post-2010) (pirinixic acid) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 865 | 2 | 200 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behnk, A; Günther, A; Hecker, M; Mayer, K; Ott, J; Pose, A; Schaefer, MB; Schulz, R; Seeger, W; Weissmann, N | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pirinixic acid
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-alpha reduces inflammation and vascular leakage in a murine model of acute lung injury.
Topics: Acute Lung Injury; Animals; Capillaries; Disease Models, Animal; Endotoxins; Inflammation; Lipopolysaccharides; Mice; Mice, Transgenic; Peroxisome Proliferators; Platelet Activating Factor; PPAR alpha; Pressure; Pulmonary Artery; Pyrimidines | 2008 |